HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment-Reference-Cited by-同舟云学术

HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment

Published:2022-01-31 Issue:2 Volume:15 Page:301-309
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Burlone Michela E.,Bellan Mattia,Barbaglia Matteo N.,Mocchetti Ginevra,Mallela Venkata R.,Minisini Rosalba^ORCID,Rigamonti Cristina,Pirisi Mario

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12328-021-01578-1.pdf

Reference50 articles.

1. Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann Intern Med. 2017;166(9):637–48 (Epub 2017/03/21).

2. Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, et al. Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications. Gastroenterology. 2017;152(1):142-156e2 (Epub 2016/09/20).

3. Roche B, Coilly A, Duclos-Vallee JC, Samuel D. The impact of treatment of hepatitis C with DAAs on the occurrence of HCC. Liver Int. 2018;38(Suppl 1):139–45 (Epub 2018/02/11).

4. Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol. 2016;65(4):727–33 (Epub 2016/06/29).

5. Reig M, Marino Z, Perello C, Inarrairaegui M, Ribeiro A, Lens S, et al. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J Hepatol. 2016;65(4):719–26 (Epub 2016/04/17).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases;Seminars in Liver Disease;2023-10-05

2. MBOAT7 in liver and extrahepatic diseases;Liver International;2023-08-22

3. Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD;Alimentary Pharmacology & Therapeutics;2022-11-09